Firms to develop freeze-dried human plasma

Entegrion and Kedrion Melville agreed to collaborate in the development and commercialization of the former's freeze-dried human plasma Resusix, a shelf-stable alternative to fresh-frozen plasma. The partners plan to initiate clinical studies this year. Kedrion will invest in Entegrion under the agreement.

View Full Article in:

American City Business Journals · WRALTechWire.com (Raleigh, N.C.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID